Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


New Amedeo service:

Amedeo COVID-19 (formerly 2019-nCoV)

Weekly publication summary

  Breast Cancer

  Free Subscription


Articles published in Clin Breast Cancer

Retrieve available abstracts of 290 articles:
HTML format
Text format



Single Articles


    January 2020
  1. KITTANEH M, Badve S, Caldera H, Coleman R, et al
    Case-Based Review and Clinical Guidance on the Use of Genomic Assays for Early-Stage Breast Cancer: Breast Cancer Therapy Expert Group (BCTEG).
    Clin Breast Cancer. 2020 Jan 8. pii: S1526-8209(20)30004.
    PubMed     Text format     Abstract available


  2. FARD ZT
    The Relationship Between eNOS Polymorphisms With Age, Smoking, Body Mass Index, and Clinicopathologic Parameters in Patients With Breast Cancer in Comparison With a Control Group.
    Clin Breast Cancer. 2020 Jan 7. pii: S1526-8209(20)30003.
    PubMed     Text format     Abstract available


  3. RASHAD N, Abdelhamid T, Shouman SA, Nassar H, et al
    Capecitabine-Based Chemoendocrine Combination as First-Line Treatment for Metastatic Hormone-Positive Metastatic Breast Cancer: Phase 2 Study.
    Clin Breast Cancer. 2020 Jan 7. pii: S1526-8209(20)30002.
    PubMed     Text format     Abstract available


    December 2019
  4. NACK E, Koffer PP, Blumberg CS, Leonard KL, et al
    New Cardiac Abnormalities After Radiotherapy in Breast Cancer Patients Treated With Trastuzumab.
    Clin Breast Cancer. 2019 Dec 19. pii: S1526-8209(19)30765.
    PubMed     Text format     Abstract available


  5. MODI ND, Sorich MJ, Rowland A, McKinnon RA, et al
    Predicting Thrombocytopenia in Patients With Breast Cancer Treated With Ado-trastuzumab Emtansine.
    Clin Breast Cancer. 2019 Dec 7. pii: S1526-8209(19)30715.
    PubMed     Text format     Abstract available


  6. TKACZUK KHR, Hawkins D, Yue B, Hicks D, et al
    Association of Serum Progranulin Levels With Disease Progression, Therapy Response and Survival in Patients With Metastatic Breast Cancer.
    Clin Breast Cancer. 2019 Dec 5. pii: S1526-8209(19)30758.
    PubMed     Text format     Abstract available


  7. HOPSON MB, Onishi M, Awad D, Buono D, et al
    Prospective Study Evaluating Changes in Bone Quality in Premenopausal Women With Breast Cancer Undergoing Adjuvant Chemotherapy.
    Clin Breast Cancer. 2019 Dec 5. pii: S1526-8209(19)30759.
    PubMed     Text format     Abstract available


    November 2019
  8. BROWN CL, McEvoy MP, Smith BL, Lanahan CR, et al
    Long-Term Outcomes of Multiple-Wire Localizations for More Extensive Breast Cancer: Multiple-Wire Excision Does Not Increase Recurrence, Unplanned Imaging, or Biopsies.
    Clin Breast Cancer. 2019 Nov 23. pii: S1526-8209(19)30737.
    PubMed     Text format     Abstract available


  9. ITANI N, Grogan N, Mott S, Phadke S, et al
    Metastatic Presentations of Previously Treated Early-Stage Breast Cancer Patients and Association With Survival.
    Clin Breast Cancer. 2019 Nov 21. pii: S1526-8209(19)30735.
    PubMed     Text format     Abstract available


    October 2019
  10. SABOUR S
    The Impact of Partial Weak Staining in Normal Breast Epithelium on the Reliability of Immunohistochemistry Results in HercepTest-positive Breast Cancer: Methodological Issues on Reliability and Correlation.
    Clin Breast Cancer. 2019 Oct 25. pii: S1526-8209(19)30716.
    PubMed     Text format    


  11. PAULSSON AK, Fowble B, Lazar AA, Park C, et al
    Radiotherapy Utilization for Patients Over Age 60 With Early Stage Breast Cancer.
    Clin Breast Cancer. 2019 Oct 25. pii: S1526-8209(19)30719.
    PubMed     Text format     Abstract available


  12. CONTE B, Fabi A, Poggio F, Blondeaux E, et al
    T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study.
    Clin Breast Cancer. 2019 Oct 24. pii: S1526-8209(19)30671.
    PubMed     Text format     Abstract available


  13. SMITH J 2ND, Irwin A, Jensen L, Tedesco K, et al
    Phase II Study of Eribulin Mesylate Administered Biweekly in Patients With Human Epidermal Growth Factor Receptor-2-negative Metastatic Breast Cancer.
    Clin Breast Cancer. 2019 Oct 14. pii: S1526-8209(19)30714.
    PubMed     Text format     Abstract available


    September 2019
  14. KIM K, Kim SS, Shin KH, Kim JH, et al
    Aggressive Surgical Excision of Supraclavicular Lymph Node Did Not Improve the Outcomes of Breast Cancer With Supraclavicular Lymph Node Involvement (KROG 16-14).
    Clin Breast Cancer. 2019 Sep 24. pii: S1526-8209(19)30684.
    PubMed     Text format     Abstract available


  15. MEISEL JL, Zhao J, Suo A, Zhang C, et al
    Clinicopathologic Factors Associated With Response to Neoadjuvant Anti-HER2-Directed Chemotherapy in HER2-Positive Breast Cancer.
    Clin Breast Cancer. 2019 Sep 18. pii: S1526-8209(19)30683.
    PubMed     Text format     Abstract available


  16. WANG D, Yang X, He J, Lin J, et al
    Impact of Regional Nodal Irradiation and Hypofractionated Whole-Breast Radiation on Long-Term Breast Retraction and Poor Cosmetic Outcome in Breast Cancer Survivors.
    Clin Breast Cancer. 2019 Sep 18. pii: S1526-8209(19)30665.
    PubMed     Text format     Abstract available


  17. LI Y, Wang YW, Chen X, Ma RR, et al
    MicroRNA-4472 Promotes Tumor Proliferation and Aggressiveness in Breast Cancer by Targeting RGMA and Inducing EMT.
    Clin Breast Cancer. 2019 Sep 11. pii: S1526-8209(19)30669.
    PubMed     Text format     Abstract available


  18. TAKAHASHI Y, Iwamoto T, Suzuki Y, Kajiwara Y, et al
    Evaluation of Therapeutic Target Gene Expression Based on Residual Cancer Burden Classification After Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer.
    Clin Breast Cancer. 2019 Sep 9. pii: S1526-8209(19)30643.
    PubMed     Text format     Abstract available


  19. OZAKI A, Nomura S, Leppold C, Tsubokura M, et al
    Breast Cancer Provider Interval Length in Fukushima, Japan, After the 2011 Triple Disaster: A Long-Term Retrospective Study.
    Clin Breast Cancer. 2019 Sep 6. pii: S1526-8209(19)30652.
    PubMed     Text format     Abstract available


  20. RAZIS E, Kalogeras KT, Kotsantis I, Koliou GA, et al
    The Role of CXCL13 and CXCL9 in Early Breast Cancer.
    Clin Breast Cancer. 2019 Sep 5. pii: S1526-8209(19)30667.
    PubMed     Text format     Abstract available


  21. RUGO HS, Finn RS, Gelmon K, Joy AA, et al
    Progression-free Survival Outcome Is Independent of Objective Response in Patients With Estrogen Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Advanced Breast Cancer Treated With Palbociclib Plus Letrozole Compared With Letrozol
    Clin Breast Cancer. 2019 Sep 5. pii: S1526-8209(19)30668.
    PubMed     Text format     Abstract available


  22. BINES J, Procter M, Restuccia E, Viale G, et al
    Incidence and Management of Diarrhea With Adjuvant Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
    Clin Breast Cancer. 2019 Sep 5. pii: S1526-8209(19)30656.
    PubMed     Text format     Abstract available


  23. KUO WL, Huang JJ, Huang YT, Chueh LF, et al
    Robot-assisted Mastectomy Followed by Immediate Autologous Microsurgical Free Flap Reconstruction: Techniques and Feasibility in Three Different Breast Cancer Surgical Scenarios.
    Clin Breast Cancer. 2019 Sep 4. pii: S1526-8209(19)30662.
    PubMed     Text format    


  24. WU W, Zhong J, Chen J, Niu P, et al
    Prognostic and Therapeutic Significance of Adhesion-regulating Molecule 1 in Estrogen Receptor-positive Breast Cancer.
    Clin Breast Cancer. 2019 Sep 3. pii: S1526-8209(19)30654.
    PubMed     Text format     Abstract available


    August 2019
  25. LIU D, Zhou K
    BRAF/MEK Pathway is Associated With Breast Cancer in ER-dependent Mode and Improves ER Status-based Cancer Recurrence Prediction.
    Clin Breast Cancer. 2019 Aug 29. pii: S1526-8209(19)30664.
    PubMed     Text format     Abstract available


  26. FENN K, Maurer M, Lee SM, Crew KD, et al
    Phase 1 Study of Erlotinib and Metformin in Metastatic Triple-Negative Breast Cancer.
    Clin Breast Cancer. 2019 Aug 29. pii: S1526-8209(19)30663.
    PubMed     Text format     Abstract available


  27. SAMMONS S, Shastry M, Dent S, Anders C, et al
    Practical Treatment Strategies and Future Directions After Progression While Receiving CDK4/6 Inhibition and Endocrine Therapy in Advanced HR(+)/HER2(-) Breast Cancer.
    Clin Breast Cancer. 2019 Aug 23. pii: S1526-8209(19)30659.
    PubMed     Text format     Abstract available


  28. LI Z, Tu Y, Wu Q, Wang Z, et al
    Clinical Characteristics and Outcomes of Single Versus Double Hormone Receptor-Positive Breast Cancer in 2 Large Databases.
    Clin Breast Cancer. 2019 Aug 22. pii: S1526-8209(19)30644.
    PubMed     Text format     Abstract available


  29. FREEDMAN RA, Gelman RS, Agar NYR, Santagata S, et al
    Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022.
    Clin Breast Cancer. 2019 Aug 22. pii: S1526-8209(19)30657.
    PubMed     Text format     Abstract available


  30. JIANG L, Li X, Kong X, Ma T, et al
    Galactogram Grading System for Identifying Breast Cancer With Nipple Discharge.
    Clin Breast Cancer. 2019 Aug 22. pii: S1526-8209(19)30658.
    PubMed     Text format     Abstract available


  31. LASHAM A, Fitzgerald SJ, Knowlton N, Robb T, et al
    A Predictor of Early Disease Recurrence in Patients With Breast Cancer Using a Cell-free RNA and Protein Liquid Biopsy.
    Clin Breast Cancer. 2019 Aug 22. pii: S1526-8209(19)30645.
    PubMed     Text format     Abstract available


  32. YOO SH, Kim TY, Kim M, Lee KH, et al
    Development of a Nomogram to Predict the Recurrence Score of 21-Gene Prediction Assay in Hormone Receptor-Positive Early Breast Cancer.
    Clin Breast Cancer. 2019 Aug 21. pii: S1526-8209(19)30655.
    PubMed     Text format     Abstract available


  33. PAVLOVIC R, Jankovic SM, Milovanovic JR, Stefanovic SM, et al
    The Safety of Local Hormonal Treatment for Vulvovaginal Atrophy in Women With Estrogen Receptor-positive Breast Cancer Who Are on Adjuvant Aromatase Inhibitor Therapy: Meta-analysis.
    Clin Breast Cancer. 2019 Aug 21. pii: S1526-8209(19)30651.
    PubMed     Text format     Abstract available


  34. DU Q, Che J, Jiang X, Li L, et al
    PD-L1 Acts as a Promising Immune Marker to Predict the Response to Neoadjuvant Chemotherapy in Breast Cancer Patients.
    Clin Breast Cancer. 2019 Aug 21. pii: S1526-8209(19)30649.
    PubMed     Text format     Abstract available


  35. GUO JY, Wang MZ, Wang MS, Sun T, et al
    The Undervalued Effects of Polychlorinated Biphenyl Exposure on Breast Cancer.
    Clin Breast Cancer. 2019 Aug 21. pii: S1526-8209(19)30648.
    PubMed     Text format     Abstract available


  36. ABDEL-RAHMAN O
    Impact of NCI Socioeconomic Index on the Outcomes of Nonmetastatic Breast Cancer Patients: Analysis of SEER Census Tract-Level Socioeconomic Database.
    Clin Breast Cancer. 2019 Aug 21. pii: S1526-8209(19)30647.
    PubMed     Text format     Abstract available


  37. YOON GY, Chae EY, Cha JH, Shin HJ, et al
    Imaging and Clinicopathologic Features Associated With Pathologic Complete Response in HER2-positive Breast Cancer Receiving Neoadjuvant Chemotherapy With Dual HER2 Blockade.
    Clin Breast Cancer. 2019 Aug 21. pii: S1526-8209(19)30653.
    PubMed     Text format     Abstract available


    July 2019
  38. SINGH J, Asad S, Zhang Y, Nock W, et al
    Aggressive Subsets of Metastatic Triple Negative Breast Cancer.
    Clin Breast Cancer. 2019 Jul 31. pii: S1526-8209(19)30160.
    PubMed     Text format     Abstract available


  39. TOSS A, Venturelli M, Sperduti I, Molinaro E, et al
    First-Line Treatment for Endocrine-Sensitive Bone-Only Metastatic Breast Cancer: Systematic Review and Meta-analysis.
    Clin Breast Cancer. 2019 Jul 24. pii: S1526-8209(19)30418.
    PubMed     Text format     Abstract available


  40. WILKIE J, Schickli MA, Berger MJ, Lustberg M, et al
    Progression-Free Survival for Real-World Use of Palbociclib in Hormone Receptor-Positive Metastatic Breast Cancer.
    Clin Breast Cancer. 2019 Jul 17. pii: S1526-8209(19)30112.
    PubMed     Text format     Abstract available


  41. CANTINI L, Pistelli M, Merloni F, Fontana A, et al
    Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients.
    Clin Breast Cancer. 2019 Jul 11. pii: S1526-8209(19)30081.
    PubMed     Text format     Abstract available


  42. DONG J, Esham KS, Boehm L, Karim SA, et al
    Timeliness of Treatment Initiation in Newly Diagnosed Patients With Breast Cancer.
    Clin Breast Cancer. 2019 Jul 11. pii: S1526-8209(18)30831.
    PubMed     Text format     Abstract available


  43. KOMOROWSKI AS, Warner E, MacKay HJ, Sahgal A, et al
    Incidence of Brain Metastases in Nonmetastatic and Metastatic Breast Cancer: Is There a Role for Screening?
    Clin Breast Cancer. 2019 Jul 11. pii: S1526-8209(18)30863.
    PubMed     Text format     Abstract available


    June 2019
  44. BLAND KA, Kirkham AA, Bovard J, Shenkier T, et al
    Effect of Exercise on Taxane Chemotherapy-Induced Peripheral Neuropathy in Women With Breast Cancer: A Randomized Controlled Trial.
    Clin Breast Cancer. 2019 Jun 27. pii: S1526-8209(19)30253.
    PubMed     Text format     Abstract available


  45. CATTELL RF, Kang JJ, Ren T, Huang PB, et al
    MRI Volume Changes of Axillary Lymph Nodes as Predictor of Pathologic Complete Responses to Neoadjuvant Chemotherapy in Breast Cancer.
    Clin Breast Cancer. 2019 Jun 26. pii: S1526-8209(19)30037.
    PubMed     Text format     Abstract available


  46. FERREIRA AR, Ribeiro J, Miranda A, Mayer A, et al
    Effectiveness of Adjuvant Ovarian Function Suppression in Premenopausal Women With Early Breast Cancer: A Multicenter Cohort Study.
    Clin Breast Cancer. 2019 Jun 26. pii: S1526-8209(19)30263.
    PubMed     Text format     Abstract available


  47. YARDLEY DA, Liggett W, Mainwaring M, Castrellon A, et al
    A Phase II Open Label Study of Everolimus in Combination With Endocrine Therapy in Resistant Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer.
    Clin Breast Cancer. 2019 Jun 26. pii: S1526-8209(19)30164.
    PubMed     Text format     Abstract available


  48. PATHAK M, Dwivedi SN, Deo SVS, Thakur B, et al
    Effectiveness of Added Targeted Therapies to Neoadjuvant Chemotherapy for Breast Cancer: A Systematic Review and Meta-analysis.
    Clin Breast Cancer. 2019 Jun 20. pii: S1526-8209(19)30323.
    PubMed     Text format     Abstract available


  49. JIANG Y, Liu Y, Tan X, Yu S, et al
    TPX2 as a Novel Prognostic Indicator and Promising Therapeutic Target in Triple-negative Breast Cancer.
    Clin Breast Cancer. 2019 Jun 13. pii: S1526-8209(18)30866.
    PubMed     Text format     Abstract available


  50. LEVASSEUR N, Willemsma KA, Li H, Gondara L, et al
    Efficacy of Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in ER-positive Breast Cancer: Results From a Prospective Institutional Database.
    Clin Breast Cancer. 2019 Jun 11. pii: S1526-8209(19)30033.
    PubMed     Text format     Abstract available


  51. ROSSI L, McCartney A, Risi E, De Santo I, et al
    Cyclin-Dependent Kinase 4/6 Inhibitors in Neoadjuvant Endocrine Therapy of Hormone Receptor-Positive Breast Cancer.
    Clin Breast Cancer. 2019 Jun 11. pii: S1526-8209(19)30307.
    PubMed     Text format     Abstract available


  52. LIVINGSTON-ROSANOFF D, Schumacher J, Vande Walle K, Stankowski-Drengler T, et al
    Does Tumor Size Predict Response to Neoadjuvant Chemotherapy in the Modern Era of Biologically Driven Treatment? A Nationwide Study of US Breast Cancer Patients.
    Clin Breast Cancer. 2019 Jun 6. pii: S1526-8209(19)30303.
    PubMed     Text format     Abstract available


  53. FARES J, Kanojia D, Rashidi A, Ahmed AU, et al
    Diagnostic Clinical Trials in Breast Cancer Brain Metastases: Barriers and Innovations.
    Clin Breast Cancer. 2019 Jun 5. pii: S1526-8209(19)30262.
    PubMed     Text format     Abstract available


  54. BOEHM L, Weisberg T, Linendoll N, Damon AC, et al
    Development of Phase-Specific Breast Cancer Survivorship Care Plans.
    Clin Breast Cancer. 2019 Jun 5. pii: S1526-8209(19)30138.
    PubMed     Text format     Abstract available


    May 2019
  55. VAHEDNIA E, Shandiz FH, Bagherabad MB, Moezzi A, et al
    The Impact of CASP8 rs10931936 and rs1045485 Polymorphisms as well as the Haplotypes on Breast Cancer Risk: A Case-Control Study.
    Clin Breast Cancer. 2019 May 31. pii: S1526-8209(18)30646.
    PubMed     Text format     Abstract available


  56. GOEL S, Pernas S, Tan-Wasielewski Z, Barry WT, et al
    Ribociclib Plus Trastuzumab in Advanced HER2-Positive Breast Cancer: Results of a Phase 1b/2 Trial.
    Clin Breast Cancer. 2019 May 30. pii: S1526-8209(19)30313.
    PubMed     Text format     Abstract available


  57. LI H, Chen Y, Wang X, Tang L, et al
    T1-2N0M0 Triple-Negative Breast Cancer Treated With Breast-Conserving Therapy Has Better Survival Compared to Mastectomy: A SEER Population-Based Retrospective Analysis.
    Clin Breast Cancer. 2019 May 30. pii: S1526-8209(19)30316.
    PubMed     Text format     Abstract available


  58. LAFRENIE RM, Speigl L, Buckner CA, Pawelec G, et al
    Frequency of Immune Cell Subtypes in Peripheral Blood Correlates With Outcome for Patients With Metastatic Breast Cancer Treated With High-Dose Chemotherapy.
    Clin Breast Cancer. 2019 May 27. pii: S1526-8209(19)30015.
    PubMed     Text format     Abstract available


  59. DREHER N, Hadeler EK, Hartman SJ, Wong EC, et al
    Fitbit Usage in Patients With Breast Cancer Undergoing Chemotherapy.
    Clin Breast Cancer. 2019 May 25. pii: S1526-8209(19)30229.
    PubMed     Text format     Abstract available


  60. HARPER NW, Hodges KB, Stewart RL, Wu J, et al
    Adjuvant Treatment of Triple-Negative Metaplastic Breast Cancer With Weekly Paclitaxel and Platinum Chemotherapy: Retrospective Case Review From a Single Institution.
    Clin Breast Cancer. 2019 May 24. pii: S1526-8209(19)30123.
    PubMed     Text format    


  61. PARK G, Bae K, Hwang IY, Kim JS, et al
    Prediction of Residual Malignancy After Excisional Biopsy for Breast Cancer With Suspicious Microcalcifications: Comparison of Mammography and Magnetic Resonance Imaging.
    Clin Breast Cancer. 2019 May 18. pii: S1526-8209(19)30289.
    PubMed     Text format     Abstract available


  62. CHOW S, Wan BA, Pidduck W, Zhang L, et al
    Symptoms Predictive of Overall Quality of Life Using the Edmonton Symptom Assessment Scale in Breast Cancer Patients Receiving Radiotherapy.
    Clin Breast Cancer. 2019 May 18. pii: S1526-8209(19)30055.
    PubMed     Text format     Abstract available


  63. FARRA C, Fedda F, Tfayli A, Tawil A, et al
    The Impact of Partial Weak Staining in Normal Breast Epithelium on the Reliability of Immunohistochemistry Results in HercepTest-positive Breast Cancer.
    Clin Breast Cancer. 2019 May 18. pii: S1526-8209(18)30847.
    PubMed     Text format     Abstract available


  64. GORI S, Puglisi F, Moroso S, Fabi A, et al
    The HERBA Study: A Retrospective Multi-Institutional Italian Study on Patients With Brain Metastases From HER2-Positive Breast Cancer.
    Clin Breast Cancer. 2019 May 18. pii: S1526-8209(19)30011.
    PubMed     Text format     Abstract available


  65. ZHOU Y, Simmons J, Jordan CD, Sonbol MB, et al
    Aspirin Treatment Effect and Association with PIK3CA Mutation in Breast Cancer: A Biomarker Analysis.
    Clin Breast Cancer. 2019 May 18. pii: S1526-8209(19)30066.
    PubMed     Text format     Abstract available


  66. GAO F, Ge R
    LOC643714 Polymorphisms Contribute to an Elevated Susceptibility to Breast Cancer: A Meta-analysis of 231,191 Subjects.
    Clin Breast Cancer. 2019 May 18. pii: S1526-8209(19)30241.
    PubMed     Text format     Abstract available


  67. STUEBER TN, Wischnewsky M, Leinert E, Diessner J, et al
    B(2) Prognostic Score: External Validation of a Clinical Decision-making Tool for Metastatic Breast Cancer.
    Clin Breast Cancer. 2019 May 3. pii: S1526-8209(18)30867.
    PubMed     Text format     Abstract available


  68. UPSHAW JN, Ruthazer R, Miller KD, Parsons SK, et al
    Personalized Decision Making in Early Stage Breast Cancer: Applying Clinical Prediction Models for Anthracycline Cardiotoxicity and Breast Cancer Mortality Demonstrates Substantial Heterogeneity of Benefit-Harm Trade-off.
    Clin Breast Cancer. 2019 May 2. pii: S1526-8209(18)30571.
    PubMed     Text format     Abstract available


    April 2019
  69. JHA S, Wyld L, Krishnaswamy PH
    The Impact of Vaginal Laser Treatment for Genitourinary Syndrome of Menopause in Breast Cancer Survivors: A Systematic Review and Meta-analysis.
    Clin Breast Cancer. 2019 Apr 19. pii: S1526-8209(19)30078.
    PubMed     Text format     Abstract available


  70. XU L, Zhang Z, Xiang Q, Liu Q, et al
    Extended Adjuvant Therapy With Aromatase Inhibitors for Early Breast Cancer: A Meta-analysis of Randomized Controlled Trials.
    Clin Breast Cancer. 2019 Apr 19. pii: S1526-8209(18)30531.
    PubMed     Text format     Abstract available


  71. BRUFSKY A, Mitra D, Davis KL, Nagar SP, et al
    Treatment Patterns and Outcomes Associated With Palbociclib Plus Letrozole for Postmenopausal Women With HR(-)/HER2(-) Advanced Breast Cancer Enrolled in an Expanded Access Program.
    Clin Breast Cancer. 2019 Apr 18. pii: S1526-8209(18)30809.
    PubMed     Text format     Abstract available


  72. MRUGALA MM, Kim B, Sharma A, Johnson N, et al
    Phase II Study of Systemic High-dose Methotrexate and Intrathecal Liposomal Cytarabine for Treatment of Leptomeningeal Carcinomatosis From Breast Cancer.
    Clin Breast Cancer. 2019 Apr 18. pii: S1526-8209(19)30099.
    PubMed     Text format     Abstract available


  73. GORNES H, Cabarrou B, Jouve E, Franchet C, et al
    Long-Term Follow-up of Immediate Latissimus Dorsi Flap Reconstruction After Neoadjuvant Chemotherapy and Radiotherapy for Invasive Breast Cancer.
    Clin Breast Cancer. 2019 Apr 17. pii: S1526-8209(19)30018.
    PubMed     Text format     Abstract available


  74. LI Y, Cui X, Yang YJ, Chen QQ, et al
    Serum sPD-1 and sPD-L1 as Biomarkers for Evaluating the Efficacy of Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients.
    Clin Breast Cancer. 2019 Apr 11. pii: S1526-8209(18)30653.
    PubMed     Text format     Abstract available


  75. TIAINEN L, Hamalainen M, Luukkaala T, Tanner M, et al
    Low Plasma IL-8 Levels During Chemotherapy Are Predictive of Excellent Long-Term Survival in Metastatic Breast Cancer.
    Clin Breast Cancer. 2019 Apr 4. pii: S1526-8209(18)30840.
    PubMed     Text format     Abstract available


    March 2019
  76. NAMURA M, Tsunoda H, Kobayashi D, Enokido K, et al
    The Loss of Lymph Node Metastases After Neoadjuvant Chemotherapy in Patients With Cytology-proven Axillary Node-positive Primary Breast Cancer.
    Clin Breast Cancer. 2019 Mar 11. pii: S1526-8209(18)30858.
    PubMed     Text format     Abstract available


  77. SILVER E, Wenger N, Xie Z, Elashoff D, et al
    Implementing a Population-Based Breast Cancer Risk Assessment Program.
    Clin Breast Cancer. 2019 Mar 11. pii: S1526-8209(18)30761.
    PubMed     Text format     Abstract available


  78. NUGENT BD, Ren D, Bender CM, Rosenzweig M, et al
    The Impact of Age and Adjuvant Chemotherapy Modifications on Survival Among Black Women With Breast Cancer.
    Clin Breast Cancer. 2019 Mar 7. pii: S1526-8209(18)30643.
    PubMed     Text format     Abstract available


  79. LARSEN V, Barlow WE, Yang JJ, Zhu Q, et al
    Germline Genetic Variants in GATA3 and Breast Cancer Treatment Outcomes in SWOG S8897 Trial and the Pathways Study.
    Clin Breast Cancer. 2019 Mar 6. pii: S1526-8209(18)30783.
    PubMed     Text format     Abstract available


  80. ALTUNDAG K
    Characteristics of Patients With Breast Cancer With Brain Metastases Who Live Longer Than 60 Months.
    Clin Breast Cancer. 2019 Mar 6. pii: S1526-8209(19)30105.
    PubMed     Text format    


    February 2019
  81. WOODWARD N, De Boer RH, Redfern A, White M, et al
    Results From the First Multicenter, Open-label, Phase IIIb Study Investigating the Combination of Pertuzumab With Subcutaneous Trastuzumab and a Taxane in Patients With HER2-positive Metastatic Breast Cancer (SAPPHIRE).
    Clin Breast Cancer. 2019 Feb 27. pii: S1526-8209(18)30696.
    PubMed     Text format     Abstract available


  82. LANDERCASPER J, Ramirez LD, Borgert AJ, Ahmad HF, et al
    A Reappraisal of the Comparative Effectiveness of Lumpectomy Versus Mastectomy on Breast Cancer Survival: A Propensity Score-Matched Update From the National Cancer Data Base (NCDB).
    Clin Breast Cancer. 2019 Feb 21. pii: S1526-8209(18)30861.
    PubMed     Text format     Abstract available


  83. MATRAI Z, Ujhelyi M, Kovacs T, Kelemen P, et al
    Evaluation of a Retroglandular Oncoplastic Technique as a Standard Level I Oncoplastic Breast-Conserving Surgery: A Retrospective Clinicopathologic Study of 102 Patients With Breast Cancer.
    Clin Breast Cancer. 2019 Feb 20. pii: S1526-8209(18)30884.
    PubMed     Text format     Abstract available


  84. GIULIANI J, Bonetti A
    Palbociclib or Ribociclib in First-Line Treatment in Patients With Hormone Receptor-Positive/Human Epidermal Receptor 2-Negative Advanced or Metastatic Breast Cancer? A Perspective Based on Pharmacologic Costs.
    Clin Breast Cancer. 2019 Feb 16. pii: S1526-8209(18)30803.
    PubMed     Text format     Abstract available


  85. ARCIERO CA, Guo Y, Jiang R, Behera M, et al
    ER(+)/HER2(+) Breast Cancer Has Different Metastatic Patterns and Better Survival Than ER-/HER2(+) Breast Cancer.
    Clin Breast Cancer. 2019 Feb 14. pii: S1526-8209(18)30792.
    PubMed     Text format     Abstract available


  86. XIE Y, Li Y, Zhang Y, Zhang S, et al
    Fulvestrant 500 mg Versus Exemestane in Postmenopausal Women With Metastatic Breast Cancer Resistant to Adjuvant Nonsteroidal Aromatase Inhibitors in Clinical Practice: A Multicenter Retrospective Study.
    Clin Breast Cancer. 2019 Feb 7. pii: S1526-8209(18)30801.
    PubMed     Text format     Abstract available


  87. HENDERSON J, Adams P, Barber K
    Factors Determining Anthracycline Use in Hormone Receptor Positive, Early-Stage Breast Cancer.
    Clin Breast Cancer. 2019 Feb 7. pii: S1526-8209(18)30542.
    PubMed     Text format     Abstract available


  88. KLAR N, Rosenzweig M, Diergaarde B, Brufsky A, et al
    Features Associated With Long-Term Survival in Patients With Metastatic Breast Cancer.
    Clin Breast Cancer. 2019 Feb 6. pii: S1526-8209(18)30853.
    PubMed     Text format     Abstract available


  89. O'BRIEN GL, O'Mahony C, Cooke K, Kinneally A, et al
    Cost Minimization Analysis of Intravenous or Subcutaneous Trastuzumab Treatment in Patients With HER2-Positive Breast Cancer in Ireland.
    Clin Breast Cancer. 2019 Feb 6. pii: S1526-8209(18)30526.
    PubMed     Text format     Abstract available


  90. NATSIOPOULOS I, Intzes S, Liappis T, Zarampoukas K, et al
    Axillary Lymph Node Tattooing and Targeted Axillary Dissection in Breast Cancer Patients Who Presented as cN+ Before Neoadjuvant Chemotherapy and Became cN0 After Treatment.
    Clin Breast Cancer. 2019 Feb 6. pii: S1526-8209(18)30845.
    PubMed     Text format     Abstract available


    January 2019
  91. FERRIGNI E, Bergom C, Yin Z, Szabo A, et al
    Breast Cancer in Women Aged 80 Years or Older: An Analysis of Treatment Patterns and Disease Outcomes.
    Clin Breast Cancer. 2019 Jan 31. pii: S1526-8209(18)30705.
    PubMed     Text format     Abstract available


  92. HU J, Cuffolo G, Parulekar V, Chan V, et al
    The Results of Surveillance Imaging After Breast Conservation Surgery and Partial Breast Reconstruction With Chest Wall Perforator Flaps; A Qualitative Analysis Compared With Standard Breast-Conserving Surgery for Breast Cancer.
    Clin Breast Cancer. 2019 Jan 31. pii: S1526-8209(18)30842.
    PubMed     Text format     Abstract available


  93. OGIYA R, Sagara Y, Niikura N, Freedman RA, et al
    Impact of Subtype on Survival of Young Patients With Stage IV Breast Cancer.
    Clin Breast Cancer. 2019 Jan 29. pii: S1526-8209(18)30604.
    PubMed     Text format     Abstract available


  94. MAAJANI K, Jalali A, Alipour S, Khodadost M, et al
    The Global and Regional Survival Rate of Women With Breast Cancer: A Systematic Review and Meta-analysis.
    Clin Breast Cancer. 2019 Jan 29. pii: S1526-8209(18)30780.
    PubMed     Text format     Abstract available


  95. ALTUNDAG DK
    Prognostic Significance of Obesity and Diabetes Mellitus in Women With Brain Metastases From Breast Cancer Should Be Revisited.
    Clin Breast Cancer. 2019 Jan 23. pii: S1526-8209(19)30021.
    PubMed     Text format    


  96. MEYER C, Millan P, Gonzalez V, Spera G, et al
    Intensive Imaging Surveillance of Survivors of Breast Cancer May Increase Risk of Radiation-induced Malignancy.
    Clin Breast Cancer. 2019 Jan 23. pii: S1526-8209(18)30713.
    PubMed     Text format     Abstract available


  97. TANGALAKIS LL, Cortina CS, Son JD, Poirier J, et al
    Obesity Does Not Influence Management of Advanced Breast Cancer in the Elderly.
    Clin Breast Cancer. 2019 Jan 12. pii: S1526-8209(18)30520.
    PubMed     Text format     Abstract available


  98. CACHO-DIAZ B, Spinola-Marono H, Reynoso N, Gonzalez-Aguilar A, et al
    Role of Overweight, Obesity, and Comorbidities in the Prognosis of Patients With Breast Cancer With Brain Metastases.
    Clin Breast Cancer. 2019 Jan 7. pii: S1526-8209(18)30766.
    PubMed     Text format     Abstract available


  99. MOTAWI TMK, Zakhary NI, Darwish HA, Abdalla HM, et al
    Significance of Serum Survivin and -31G/C Gene Polymorphism in the Early Diagnosis of Breast Cancer in Egypt.
    Clin Breast Cancer. 2019 Jan 6. pii: S1526-8209(18)30704.
    PubMed     Text format     Abstract available


  100. HEMIDA MA, AbdElmoneim NA, Hewala TI, Rashad MM, et al
    Vitamin D Receptor in Breast Cancer Tissues and Its Relation to Estrogen Receptor Alpha (ER-alpha) Gene Expression and Serum 25-hydroxyvitamin D Levels in Egyptian Breast Cancer Patients: A Case-control Study.
    Clin Breast Cancer. 2019 Jan 6. pii: S1526-8209(18)30224.
    PubMed     Text format     Abstract available


  101. PAPLOMATA E, Zelnak A, Santa-Maria CA, Liu Y, et al
    Use of Everolimus and Trastuzumab in Addition to Endocrine Therapy in Hormone-Refractory Metastatic Breast Cancer.
    Clin Breast Cancer. 2019 Jan 3. pii: S1526-8209(18)30637.
    PubMed     Text format     Abstract available


    December 2018
  102. BLASCHKE SM, Gough KC, Chua BH, Francis PA, et al
    Implementation of a Multidisciplinary Model of Care for Women With Metastatic Breast Cancer: Challenges and Lessons Learned.
    Clin Breast Cancer. 2018 Dec 21. pii: S1526-8209(18)30567.
    PubMed     Text format     Abstract available


  103. NOUR ELDIN EEM, El-Readi MZ, Nour Eldein MM, Alfalki AA, et al
    8-Hydroxy-2'-deoxyguanosine as a Discriminatory Biomarker for Early Detection of Breast Cancer.
    Clin Breast Cancer. 2018 Dec 21. pii: S1526-8209(18)30631.
    PubMed     Text format     Abstract available


  104. BLACKWELL KL, Zaman K, Qin S, Tkaczuk KHR, et al
    Neratinib in Combination With Trastuzumab for the Treatment of Patients With Advanced HER2-positive Breast Cancer: A Phase I/II Study.
    Clin Breast Cancer. 2018 Dec 20. pii: S1526-8209(18)30576.
    PubMed     Text format     Abstract available


  105. TANINI S, Fisher AD, Meattini I, Bianchi S, et al
    Testosterone and Breast Cancer in Transmen: Case Reports, Review of the Literature, and Clinical Observation.
    Clin Breast Cancer. 2018 Dec 20. pii: S1526-8209(18)30518.
    PubMed     Text format    


  106. ORTEGA V, Anton A, Garau I, Afonso N, et al
    Phase II, Multicenter, Single-arm Trial of Eribulin as First-line Therapy for Patients With Aggressive Taxane-pretreated HER2-Negative Metastatic Breast Cancer: The MERIBEL Study.
    Clin Breast Cancer. 2018 Dec 20. pii: S1526-8209(17)30144.
    PubMed     Text format     Abstract available


  107. LAN B, Ma F, Han M, Chen S, et al
    The Effect of Polymorphism in UGT1A4 on Clinical Outcomes of Adjuvant Tamoxifen Therapy for Patients With Breast Cancer in China.
    Clin Breast Cancer. 2018 Dec 19. pii: S1526-8209(18)30539.
    PubMed     Text format     Abstract available


  108. KAPILA AK, Herd A, Knife N, Chaplin P, et al
    A Prospective Cohort Study on the Impact of Reflexology in Patients With Breast Cancer Using the MYCaW Scale.
    Clin Breast Cancer. 2018 Dec 19. pii: S1526-8209(18)30423.
    PubMed     Text format     Abstract available


  109. SYMONDS L, Linden H, Gadi V, Korde L, et al
    Combined Targeted Therapies for First-line Treatment of Metastatic Triple Negative Breast Cancer-A Phase II Trial of Weekly Nab-Paclitaxel and Bevacizumab Followed by Maintenance Targeted Therapy With Bevacizumab and Erlotinib.
    Clin Breast Cancer. 2018 Dec 14. pii: S1526-8209(18)30655.
    PubMed     Text format     Abstract available


  110. ABDEL-RAHMAN O, Xu Y, Kong S, Dort J, et al
    Impact of Baseline Cardiovascular Comorbidity on Outcomes in Women With Breast Cancer: A Real-world, Population-based Study.
    Clin Breast Cancer. 2018 Dec 12. pii: S1526-8209(18)30506.
    PubMed     Text format     Abstract available


  111. VERNIERI C, Prisciandaro M, Milano M, Cona MS, et al
    Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer: A Retrospective Comparison of Efficacy and Safety Profiles.
    Clin Breast Cancer. 2018 Dec 12. pii: S1526-8209(18)30638.
    PubMed     Text format     Abstract available


  112. DENG K, Mo S, Liu X, Chen J, et al
    Soy Foods Might Weaken the Sensitivity of Tamoxifen in Premenopausal Patients With Lumina A Subtype of Breast Cancer.
    Clin Breast Cancer. 2018 Dec 12. pii: S1526-8209(18)30645.
    PubMed     Text format     Abstract available


  113. BONNER SN, Clark C, Keating NL, Kouri EM, et al
    Examining Associations of Racial Residential Segregation With Patient Knowledge of Breast Cancer and Treatment Receipt.
    Clin Breast Cancer. 2018 Dec 8. pii: S1526-8209(18)30417.
    PubMed     Text format     Abstract available


    November 2018
  114. JACENE HA, Youn T, DiPiro PJ, Hu J, et al
    Metabolic Characterization of Inflammatory Breast Cancer With Baseline FDG-PET/CT: Relationship With Pathologic Response After Neoadjuvant Chemotherapy, Receptor Status, and Tumor Grade.
    Clin Breast Cancer. 2018 Nov 26. pii: S1526-8209(18)30508.
    PubMed     Text format     Abstract available


  115. GAGNO S, D'Andrea MR, Mansutti M, Zanusso C, et al
    A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study.
    Clin Breast Cancer. 2018 Nov 24. pii: S1526-8209(18)30679.
    PubMed     Text format     Abstract available


  116. THORNELOE RJ, Horne R, Side L, Wolf MS, et al
    Beliefs About Medication and Uptake of Preventive Therapy in Women at Increased Risk of Breast Cancer: Results From a Multicenter Prospective Study.
    Clin Breast Cancer. 2018 Nov 22. pii: S1526-8209(18)30533.
    PubMed     Text format     Abstract available


  117. EISMANN J, Heng YJ, Fleischmann-Rose K, Tobias AM, et al
    Interdisciplinary Management of Transgender Individuals at Risk for Breast Cancer: Case Reports and Review of the Literature.
    Clin Breast Cancer. 2018 Nov 14. pii: S1526-8209(18)30569.
    PubMed     Text format    


  118. TANG Y, Wang Y, Wang X, Liu Y, et al
    A Genetic Variant of rs145204276 in the Promoter Region of Long Noncoding RNA GAS5 Is Associated With a Reduced Risk of Breast Cancer.
    Clin Breast Cancer. 2018 Nov 14. pii: S1526-8209(18)30454.
    PubMed     Text format     Abstract available


  119. MAINWARING W, Bowers J, Pham N, Pezzi T, et al
    Stereotactic Radiosurgery Versus Whole Brain Radiation Therapy: A Propensity Score Analysis and Predictors of Care for Patients With Brain Metastases From Breast Cancer.
    Clin Breast Cancer. 2018 Nov 12. pii: S1526-8209(18)30540.
    PubMed     Text format     Abstract available


  120. CHEN H, Zhang M, Wang M, Zhang P, et al
    Immediate Breast Reconstruction in De Novo Metastatic Breast Cancer: An Analysis of 563 Cases Based on the SEER Database.
    Clin Breast Cancer. 2018 Nov 5. pii: S1526-8209(18)30678.
    PubMed     Text format     Abstract available


  121. KOTOULA V, Tsakiri K, Koliou GA, Lazaridis G, et al
    Relapsed and De Novo Metastatic HER2-positive Breast Cancer Treated With Trastuzumab: Tumor Genotypes and Clinical Measures Associated With Patient Outcome.
    Clin Breast Cancer. 2018 Nov 5. pii: S1526-8209(18)30424.
    PubMed     Text format     Abstract available


  122. XIPING Z, Shuai Z, Feijiang Y, Bo C, et al
    Meta-analysis of the Correlation Between Schizophrenia and Breast Cancer.
    Clin Breast Cancer. 2018 Nov 3. pii: S1526-8209(18)30090.
    PubMed     Text format     Abstract available


  123. FARAROUEI M, Iqbal A, Rezaian S, Gheibi Z, et al
    Dietary Habits and Physical Activity are Associated With the Risk of Breast Cancer Among Young Iranian Women: A Case-control Study on 1010 Premenopausal Women.
    Clin Breast Cancer. 2018 Nov 2. pii: S1526-8209(18)30622.
    PubMed     Text format     Abstract available


  124. CHEN W, Zhang J, Huang L, Chen L, et al
    Detection of HER2-positive Circulating Tumor Cells Using the LiquidBiopsy System in Breast Cancer.
    Clin Breast Cancer. 2018 Nov 1. pii: S1526-8209(18)30500.
    PubMed     Text format     Abstract available


  125. WANG K, Zhu GQ, Shi Y, Li ZY, et al
    Long-Term Survival Differences Between T1-2 Invasive Lobular Breast Cancer and Corresponding Ductal Carcinoma After Breast-Conserving Surgery: A Propensity-Scored Matched Longitudinal Cohort Study.
    Clin Breast Cancer. 2018 Nov 1. pii: S1526-8209(18)30467.
    PubMed     Text format     Abstract available


    October 2018
  126. BREAUX A, Turner B, Wu X, Rai SN, et al
    Impact of 21-Gene Expression Assay on Staging Estrogen Receptor-Positive HER2-Negative Breast Cancer.
    Clin Breast Cancer. 2018 Oct 29. pii: S1526-8209(18)30561.
    PubMed     Text format     Abstract available


  127. BRANDINI DA SILVA FC, Jose da Silva J, Sarri AJ, Paiva CE, et al
    Comprehensive Validation Study of Quality-of-Life Questionnaire Using Objective Clinical Measures: Breast Cancer Treatment Outcome Scale (BCTOS), Brazilian Portuguese Version.
    Clin Breast Cancer. 2018 Oct 27. pii: S1526-8209(18)30512.
    PubMed     Text format     Abstract available


  128. PASSILDAS J, Collard O, Savoye AM, Dohou J, et al
    Impact of Chemotherapy-induced Menopause in Women of Childbearing Age With Non-metastatic Breast Cancer - Preliminary Results From the MENOCOR Study.
    Clin Breast Cancer. 2018 Oct 23. pii: S1526-8209(18)30373.
    PubMed     Text format     Abstract available


  129. HURRIA A, Soto-Perez-de-Celis E, Blanchard S, Burhenn P, et al
    A Phase II Trial of Older Adults With Metastatic Breast Cancer Receiving nab-Paclitaxel: Melding the Fields of Geriatrics and Oncology.
    Clin Breast Cancer. 2018 Oct 16. pii: S1526-8209(18)30328.
    PubMed     Text format     Abstract available


  130. DING S, Wu J, Lin C, Chen W, et al
    Predictors for Survival and Distribution of 21-Gene Recurrence Score in Patients With Pure Mucinous Breast Cancer: A SEER Population-Based Retrospective Analysis.
    Clin Breast Cancer. 2018 Oct 13. pii: S1526-8209(18)30393.
    PubMed     Text format     Abstract available


  131. KAUFMAN PA, Wildiers H, Freyer G, Kemeny M, et al
    Phase 1b Study of Trebananib Plus Paclitaxel and Trastuzumab in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer.
    Clin Breast Cancer. 2018 Oct 9. pii: S1526-8209(18)30451.
    PubMed     Text format     Abstract available


  132. PANDEY A, Brufsky AM
    Metastatic Breast Cancer Patient With Activating HER2 Exon 20 Insertion Mutation With Response to Poziotinib: Case Report of Compassionate Drug Use.
    Clin Breast Cancer. 2018 Oct 4. pii: S1526-8209(18)30317.
    PubMed     Text format    


  133. XIAO YL, Wang K, Liu Q, Li J, et al
    Risk Reduction and Survival Benefit of Risk-Reducing Salpingo-oophorectomy in Hereditary Breast Cancer: Meta-analysis and Systematic Review.
    Clin Breast Cancer. 2018 Oct 4. pii: S1526-8209(18)30521.
    PubMed     Text format     Abstract available


  134. KAPILA AK, Hamdi M, Patel A
    Clinicians Should Actively Promote Exercise in Survivors of Breast Cancer.
    Clin Breast Cancer. 2018;18:e747-e749.
    PubMed     Text format     Abstract available


  135. GINZAC A, Thivat E, Mouret-Reynier MA, Dubray-Longeras P, et al
    Weight Evolution During Endocrine Therapy for Breast Cancer in Postmenopausal Patients: Effect of Initial Fat Mass Percentage and Previous Adjuvant Treatments.
    Clin Breast Cancer. 2018;18:e1093-e1102.
    PubMed     Text format     Abstract available


    September 2018
  136. PAN H, Zhang K, Wang M, Ling L, et al
    Palliative Local Surgery for Locally Advanced Breast Cancer Depending on Hormone Receptor Status in Elderly Patients.
    Clin Breast Cancer. 2018 Sep 27. pii: S1526-8209(18)30510.
    PubMed     Text format     Abstract available


  137. NAKAGAWA M, Ikeuchi M, Morimoto M, Takechi H, et al
    Phase II Study of S-1 Combined With Low-Dose Docetaxel as Neoadjuvant Chemotherapy for Operable Breast Cancer Patients (N-1 Study).
    Clin Breast Cancer. 2018 Sep 27. pii: S1526-8209(18)30262.
    PubMed     Text format     Abstract available


  138. KOWALCZYK R, Nowosielski K, Cedrych I, Krzystanek M, et al
    Factors Affecting Sexual Function and Body Image of Early-Stage Breast Cancer Survivors in Poland: A Short-Term Observation.
    Clin Breast Cancer. 2018 Sep 21. pii: S1526-8209(18)30474.
    PubMed     Text format     Abstract available


  139. BAWAZIR A, Bashateh N, Jradi H, Breik AB, et al
    Breast Cancer Screening Awareness and Practices Among Women Attending Primary Health Care Centers in the Ghail Bawazir District of Yemen.
    Clin Breast Cancer. 2018 Sep 20. pii: S1526-8209(18)30429.
    PubMed     Text format     Abstract available


  140. SHAKER OG, Senousy MA
    Association of SNP-SNP Interactions Between RANKL, OPG, CHI3L1, and VDR Genes With Breast Cancer Risk in Egyptian Women.
    Clin Breast Cancer. 2018 Sep 19. pii: S1526-8209(18)30444.
    PubMed     Text format     Abstract available


  141. WATSON GA, Deac O, Aslam R, O'Dwyer R, et al
    Real-World Experience of Palbociclib-Induced Adverse Events and Compliance With Complete Blood Count Monitoring in Women With Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer.
    Clin Breast Cancer. 2018 Sep 8. pii: S1526-8209(18)30507.
    PubMed     Text format     Abstract available


  142. HSU W, Zhou X, Petruse A, Chau N, et al
    Role of Clinical and Imaging Risk Factors in Predicting Breast Cancer Diagnosis Among BI-RADS 4 Cases.
    Clin Breast Cancer. 2018 Sep 5. pii: S1526-8209(18)30258.
    PubMed     Text format     Abstract available


  143. MCGEE SF, Vandermeer L, Mazzarello S, Sienkiewicz M, et al
    Physician Survey of Timing of Adjuvant Endocrine Therapy Relative to Radiotherapy in Early Stage Breast Cancer Patients.
    Clin Breast Cancer. 2018 Sep 4. pii: S1526-8209(18)30204.
    PubMed     Text format     Abstract available


    August 2018
  144. BERHILI S, Ouabdelmoumen A, Sbai A, Kebdani T, et al
    Radical Mastectomy Increases Psychological Distress in Young Breast Cancer Patients: Results of A Cross-sectional Study.
    Clin Breast Cancer. 2018 Aug 31. pii: S1526-8209(18)30522.
    PubMed     Text format     Abstract available


  145. XIE J, Yang Y, Sun J, Jiao Z, et al
    STEAP1 Inhibits Breast Cancer Metastasis and Is Associated With Epithelial-Mesenchymal Transition Procession.
    Clin Breast Cancer. 2018 Aug 30. pii: S1526-8209(18)30378.
    PubMed     Text format     Abstract available


  146. HAYASHI N, Tsunoda H, Namura M, Ochi T, et al
    Magnetic Resonance Imaging Combined With Second-look Ultrasonography in Predicting Pathologic Complete Response After Neoadjuvant Chemotherapy in Primary Breast Cancer Patients.
    Clin Breast Cancer. 2018 Aug 24. pii: S1526-8209(18)30234.
    PubMed     Text format     Abstract available


  147. YARDLEY DA, Shipley D, Zubkus J, Wright GL, et al
    A Randomized Phase II Study of Eribulin/Cyclophosphamide or Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Operable HER2-negative Breast Cancer.
    Clin Breast Cancer. 2018 Aug 23. pii: S1526-8209(18)30132.
    PubMed     Text format     Abstract available


  148. PISTILLI B, Mazouni C, Zingarello A, Faron M, et al
    Individualized Prediction of Menses Recovery After Chemotherapy for Early-stage Breast Cancer: A Nomogram Developed From UNICANCER PACS04 and PACS05 Trials.
    Clin Breast Cancer. 2018 Aug 23. pii: S1526-8209(18)30264.
    PubMed     Text format     Abstract available


  149. HAMMER J, Geinitz H, Nieder C, Track C, et al
    Risk Factors for Local Relapse and Inferior Disease-free Survival After Breast-conserving Management of Breast Cancer: Recursive Partitioning Analysis of 2161 Patients.
    Clin Breast Cancer. 2018 Aug 22. pii: S1526-8209(18)30241.
    PubMed     Text format     Abstract available


  150. ALARCON ROJAS CA, Alvarez-Banuelos MT, Morales-Romero J, Suarez-Diaz H, et al
    Breast Cancer: Metastasis, Molecular Subtypes, and Overweight and Obesity in Veracruz, Mexico.
    Clin Breast Cancer. 2018 Aug 22. pii: S1526-8209(18)30366.
    PubMed     Text format     Abstract available


  151. THRIVENI K, Raju A, Kumar RV, Krishnamurthy S, et al
    Patterns of Relative Telomere Length is Associated With hTERT Gene Expression in the Tissue of Patients With Breast Cancer.
    Clin Breast Cancer. 2018 Aug 22. pii: S1526-8209(18)30372.
    PubMed     Text format     Abstract available


  152. YAN M, Abdi MA, Falkson C
    Axillary Management in Breast Cancer Patients: A Comprehensive Review of the Key Trials.
    Clin Breast Cancer. 2018 Aug 22. pii: S1526-8209(18)30448.
    PubMed     Text format     Abstract available


  153. GUILLEMOIS S, Patsouris A, Peyraga G, Chassain K, et al
    Cutaneous and Gastrointestinal Leukocytoclastic Vasculitis Induced by Palbociclib in a Metastatic Breast Cancer Patient: A Case Report.
    Clin Breast Cancer. 2018 Aug 14. pii: S1526-8209(18)30313.
    PubMed     Text format    


  154. MARSCHNER N, Salat C, Soling U, Hansen R, et al
    Final Effectiveness and Safety Results of NABUCCO: Real-World Data From a Noninterventional, Prospective, Multicenter Study in 697 Patients With Metastatic Breast Cancer Treated With nab-Paclitaxel.
    Clin Breast Cancer. 2018 Aug 9. pii: S1526-8209(18)30064.
    PubMed     Text format     Abstract available


  155. RUGO HS, Roche H, Thomas E, Chung HC, et al
    Efficacy and Safety of Ixabepilone and Capecitabine in Patients With Advanced Triple-negative Breast Cancer: a Pooled Analysis From Two Large Phase III, Randomized Clinical Trials.
    Clin Breast Cancer. 2018 Aug 4. pii: S1526-8209(18)30266.
    PubMed     Text format     Abstract available


  156. SPORIKOVA Z, Koudelakova V, Trojanec R, Hajduch M, et al
    Genetic Markers in Triple-Negative Breast Cancer.
    Clin Breast Cancer. 2018 Aug 4. pii: S1526-8209(18)30093.
    PubMed     Text format     Abstract available


  157. HE J, Gu Y, Zhang S
    Vitamin A and Breast Cancer Survival: A Systematic Review and Meta-analysis.
    Clin Breast Cancer. 2018 Aug 4. pii: S1526-8209(18)30305.
    PubMed     Text format     Abstract available


  158. JI G, Zhang C, Guan S, Yao X, et al
    Erlotinib for Progressive Brain and Leptomeningeal Metastases From HER2-positive Breast Cancer After Treatment Failure With Trastuzumab and Lapatinib: Experience and Review of Literature.
    Clin Breast Cancer. 2018 Aug 4. pii: S1526-8209(18)30384.
    PubMed     Text format    


    July 2018
  159. STEARNS V, Brufsky AM, Verma S, Cotter MJ, et al
    Expanded-Access Study of Palbociclib in Combination With Letrozole for Treatment of Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer.
    Clin Breast Cancer. 2018 Jul 30. pii: S1526-8209(18)30306.
    PubMed     Text format     Abstract available


  160. RAPHAEL J, Kiss A, Nofech-Mozes S, Trudeau M, et al
    Clinical Outcomes of Single Versus Double Hormone Receptor-Positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2018 Jul 29. pii: S1526-8209(18)30118.
    PubMed     Text format     Abstract available


  161. ALI OS, Shabayek MI, Seleem MM, Abdellateif HG, et al
    MicroRNAs 182 and 375 Sera Expression as Prognostic Biochemical Markers in Breast Cancer.
    Clin Breast Cancer. 2018 Jul 29. pii: S1526-8209(18)30232.
    PubMed     Text format     Abstract available


  162. ABDEL-RAHMAN O
    Impact of Regional Nodal Irradiation on the Outcomes of N1 Breast Cancer Patients Referred for Adjuvant Treatment: A Patient-Level Pooled Analysis of 2 Clinical Trials.
    Clin Breast Cancer. 2018 Jul 24. pii: S1526-8209(18)30085.
    PubMed     Text format     Abstract available


  163. CHEN X, Fan Y, Xu B
    Distinct Characteristics and Metastatic Behaviors of Late Recurrence in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2-negative Breast Cancer: A Single Institute Experience of More Than 10 Years.
    Clin Breast Cancer. 2018 Jul 24. pii: S1526-8209(18)30303.
    PubMed     Text format     Abstract available


  164. KURUNDKAR A, Gao X, Zhang K, Britt JP, et al
    Comparison of AJCC Anatomic and Clinical Prognostic Stage Groups in Breast Cancer: Analysis of 3322 Cases From a Single Institution.
    Clin Breast Cancer. 2018 Jul 17. pii: S1526-8209(18)30230.
    PubMed     Text format     Abstract available


  165. BUECHLER SA, Gokmen-Polar Y, Badve SS
    EarlyR: A Robust Gene Expression Signature for Predicting Outcomes of Estrogen Receptor-Positive Breast Cancer.
    Clin Breast Cancer. 2018 Jul 17. pii: S1526-8209(18)30012.
    PubMed     Text format     Abstract available


  166. MURTHY RK, Raghavendra AS, Hess KR, Fujii T, et al
    Neoadjuvant Pertuzumab-containing Regimens Improve Pathologic Complete Response Rates in Stage II to III HER-2/neu-positive Breast Cancer: A Retrospective, Single Institution Experience.
    Clin Breast Cancer. 2018 Jul 10. pii: S1526-8209(18)30009.
    PubMed     Text format     Abstract available


  167. LELIEVRE L, Clezardin P, Magaud L, Roche L, et al
    Comparative Study of Neoadjuvant Chemotherapy With and Without Zometa for Management of Locally Advanced Breast Cancer With Serum VEGF as Primary Endpoint: The NEOZOL Study.
    Clin Breast Cancer. 2018 Jul 10. pii: S1526-8209(18)30121.
    PubMed     Text format     Abstract available


  168. ABD-ELHAY FA, Elhusseiny KM, Kamel MG, Low SK, et al
    Negative Lymph Node Count and Lymph Node Ratio Are Associated With Survival in Male Breast Cancer.
    Clin Breast Cancer. 2018 Jul 7. pii: S1526-8209(18)30061.
    PubMed     Text format     Abstract available


  169. BAXTER DE, Kim B, Hanby AM, Verghese ET, et al
    Neoadjuvant Endocrine Therapy in Breast Cancer Upregulates the Cytotoxic Drug Pump ABCG2/BCRP, and May Lead to Resistance to Subsequent Chemotherapy.
    Clin Breast Cancer. 2018 Jul 6. pii: S1526-8209(18)30447.
    PubMed     Text format     Abstract available


  170. YEE C, Wang K, Asthana R, Drost L, et al
    Radiation-induced Skin Toxicity in Breast Cancer Patients: A Systematic Review of Randomized Trials.
    Clin Breast Cancer. 2018 Jul 4. pii: S1526-8209(18)30114.
    PubMed     Text format     Abstract available


    June 2018
  171. LIU N, Johnson KJ, Ma CX
    Male Breast Cancer: An Updated Surveillance, Epidemiology, and End Results Data Analysis.
    Clin Breast Cancer. 2018 Jun 27. pii: S1526-8209(18)30016.
    PubMed     Text format     Abstract available


  172. WANG J, Wang S, Tang Y, Jing H, et al
    Comparison of Treatment Outcomes With Breast-conserving Surgery Plus Radiotherapy Versus Mastectomy for Patients With Stage I Breast Cancer: A Propensity Score-matched Analysis.
    Clin Breast Cancer. 2018 Jun 27. pii: S1526-8209(18)30115.
    PubMed     Text format     Abstract available


  173. KUWAYAMA T, Nakamura S, Hayashi N, Takano T, et al
    Randomized Multicenter Phase II Trial of Neoadjuvant Therapy Comparing Weekly Nab-paclitaxel Followed by FEC With Docetaxel Followed by FEC in HER2(-) Early-stage Breast Cancer.
    Clin Breast Cancer. 2018 Jun 27. pii: S1526-8209(16)30572.
    PubMed     Text format     Abstract available


  174. NASEHI L, Sturgis CD, Sharma N, Turk P, et al
    Breast Cancer Risk Associated With Benign Intraductal Papillomas Initially Diagnosed on Core Needle Biopsy.
    Clin Breast Cancer. 2018 Jun 21. pii: S1526-8209(18)30228.
    PubMed     Text format     Abstract available


  175. SHEEHY EM, Lehane E, Quinn E, Livingstone V, et al
    Information Needs of Patients With Breast Cancer at Years One, Three, and Five After Diagnosis.
    Clin Breast Cancer. 2018 Jun 18. pii: S1526-8209(18)30130.
    PubMed     Text format     Abstract available


  176. CHEN J, Wu X, Christos P, Yan W, et al
    Adjuvant Radiation Therapy for T3N0 Breast Cancer Patients Older Than 75 Years After Mastectomy: A SEER Analysis.
    Clin Breast Cancer. 2018 Jun 15. pii: S1526-8209(17)30641.
    PubMed     Text format     Abstract available


  177. ZHU X, Huang JM, Zhang K, Xia LJ, et al
    Diagnostic Value of Contrast-Enhanced Spectral Mammography for Screening Breast Cancer: Systematic Review and Meta-analysis.
    Clin Breast Cancer. 2018 Jun 15. pii: S1526-8209(18)30008.
    PubMed     Text format     Abstract available


  178. KIM Y, Sim SH, Park B, Lee KS, et al
    Magnetic Resonance Imaging (MRI) Assessment of Residual Breast Cancer After Neoadjuvant Chemotherapy: Relevance to Tumor Subtypes and MRI Interpretation Threshold.
    Clin Breast Cancer. 2018 Jun 7. pii: S1526-8209(18)30300.
    PubMed     Text format     Abstract available


  179. MORI H, Kubo M, Kai M, Velasquez VV, et al
    BRCAness Combined With a Family History of Cancer Is Associated With a Poor Prognosis for Breast Cancer Patients With a High Risk of BRCA Mutations.
    Clin Breast Cancer. 2018 Jun 2. pii: S1526-8209(18)30022.
    PubMed     Text format     Abstract available


    May 2018
  180. SIOTOS C, McColl M, Psoter K, Gilmore RC, et al
    Tumor Site and Breast Cancer Prognosis.
    Clin Breast Cancer. 2018 May 29. pii: S1526-8209(18)30299.
    PubMed     Text format     Abstract available


  181. KIM HJ, Kang E, Kim JH, Kim SH, et al
    Survival Benefit of Surgical Removal of Primary Tumor in Patients With Stage IV Breast Cancer.
    Clin Breast Cancer. 2018 May 28. pii: S1526-8209(18)30104.
    PubMed     Text format     Abstract available


  182. CHEN M, Pockaj B, Andreozzi M, Barrett MT, et al
    JAK2 and PD-L1 Amplification Enhance the Dynamic Expression of PD-L1 in Triple-negative Breast Cancer.
    Clin Breast Cancer. 2018 May 26. pii: S1526-8209(17)30780.
    PubMed     Text format     Abstract available


  183. LECLERC AF, Slomian J, Jerusalem G, Coucke P, et al
    Exercise and Education Program After Breast Cancer: Benefits on Quality of Life and Symptoms at 3, 6, 12, and 24 Months' Follow-up.
    Clin Breast Cancer. 2018 May 19. pii: S1526-8209(17)30809.
    PubMed     Text format     Abstract available


  184. CO M, Ng J, Kwong A
    Air Travel Safety in Postoperative Breast Cancer Patients: A Systematic Review.
    Clin Breast Cancer. 2018 May 17. pii: S1526-8209(18)30236.
    PubMed     Text format     Abstract available


  185. KOZAK MM, Jacobson CE, von Eyben R, Walck E, et al
    Patterns of Distant Failure by Intrinsic Breast Cancer Subtype in Premenopausal Women Treated With Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2018 May 7. pii: S1526-8209(17)30796.
    PubMed     Text format     Abstract available


  186. MCINTIRE PJ, Irshaid L, Liu Y, Chen Z, et al
    Hot Spot and Whole-Tumor Enumeration of CD8(+) Tumor-Infiltrating Lymphocytes Utilizing Digital Image Analysis Is Prognostic in Triple-Negative Breast Cancer.
    Clin Breast Cancer. 2018 May 7. pii: S1526-8209(17)30839.
    PubMed     Text format     Abstract available


  187. DENG Y, Ma G, Li W, Wang T, et al
    CDK4/6 Inhibitors in Combination With Hormone Therapy for HR(+)/HER2(-) Advanced Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Clin Breast Cancer. 2018 May 4. pii: S1526-8209(17)30798.
    PubMed     Text format     Abstract available


  188. JABIR RS, Ho GF, Annuar MABA, Stanslas J, et al
    Association of Allelic Interaction of Single Nucleotide Polymorphisms of Influx and Efflux Transporters Genes With Nonhematologic Adverse Events of Docetaxel in Breast Cancer Patients.
    Clin Breast Cancer. 2018 May 4. pii: S1526-8209(17)30628.
    PubMed     Text format     Abstract available


    April 2018
  189. LADWA R, Kalas T, Pathmanathan S, Woodward N, et al
    Maintaining Dose Intensity of Adjuvant Chemotherapy in Older Patients With Breast Cancer.
    Clin Breast Cancer. 2018 Apr 28. pii: S1526-8209(18)30105.
    PubMed     Text format     Abstract available


  190. DHAKAL A, Matthews CM, Levine EG, Salerno KE, et al
    Efficacy of Palbociclib Combinations in Hormone Receptor-Positive Metastatic Breast Cancer Patients After Prior Everolimus Treatment.
    Clin Breast Cancer. 2018 Apr 28. pii: S1526-8209(17)30805.
    PubMed     Text format     Abstract available


  191. KOPS NL, Bessel M, Caleffi M, Ribeiro RA, et al
    Body Weight and Breast Cancer: Nested Case-Control Study in Southern Brazil.
    Clin Breast Cancer. 2018 Apr 28. pii: S1526-8209(18)30073.
    PubMed     Text format     Abstract available


  192. RAYSON D, Payne JI, Michael JCR, Tsuruda KM, et al
    Impact of Detection Method and Age on Survival Outcomes in Triple-Negative Breast Cancer: A Population-Based Cohort Analysis.
    Clin Breast Cancer. 2018 Apr 28. pii: S1526-8209(17)30829.
    PubMed     Text format     Abstract available


  193. CHO WK, Choi DH, Park W, Cha H, et al
    Effect of Body Mass Index on Survival in Breast Cancer Patients According to Subtype, Metabolic Syndrome, and Treatment.
    Clin Breast Cancer. 2018 Apr 19. pii: S1526-8209(17)30765.
    PubMed     Text format     Abstract available


  194. QINGQING H, Jian Z, Dayong Z, Ziyi F, et al
    Robot-Assisted Internal Mammary Lymph Node Chain Dissection for Breast Cancer.
    Clin Breast Cancer. 2018 Apr 19. pii: S1526-8209(18)30134.
    PubMed     Text format    


  195. KIM HJ, Lee MH, Lee JE, Park S, et al
    Oncologic Safety of Gonadotropin-Releasing Hormone Agonist for Ovarian Function Protection During Breast Cancer Chemotherapy.
    Clin Breast Cancer. 2018 Apr 19. pii: S1526-8209(18)30019.
    PubMed     Text format     Abstract available


  196. HU ZY, Xiao H, Xiao M, Tang Y, et al
    Inducing or Preventing Subsequent Malignancies for Breast Cancer Survivors? Double-edged Sword of Estrogen Receptor and Progesterone Receptor.
    Clin Breast Cancer. 2018 Apr 19. pii: S1526-8209(18)30048.
    PubMed     Text format     Abstract available


  197. KENDZIERSKI DC, Schneider BP, Kiel PJ
    Efficacy of Different Leuprolide Administration Schedules in Premenopausal Breast Cancer: A Retrospective Review.
    Clin Breast Cancer. 2018 Apr 18. pii: S1526-8209(17)30722.
    PubMed     Text format     Abstract available


  198. CADOO KA, Kaufman PA, Seidman AD, Chang C, et al
    Phase 2 Study of Dose-Dense Doxorubicin and Cyclophosphamide Followed by Eribulin Mesylate With or Without Prophylactic Growth Factor for Adjuvant Treatment of Early-Stage Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.
    Clin Breast Cancer. 2018 Apr 7. pii: S1526-8209(17)30768.
    PubMed     Text format     Abstract available


  199. NG T, Phey XY, Yeo HL, Shwe M, et al
    Impact of Adjuvant Anthracycline-Based and Taxane-Based Chemotherapy on Plasma VEGF Levels and Cognitive Function in Breast Cancer Patients: A Longitudinal Study.
    Clin Breast Cancer. 2018 Apr 6. pii: S1526-8209(17)30767.
    PubMed     Text format     Abstract available


  200. MUTSCHLER NS, Scholz C, Friedl TWP, Zwingers T, et al
    Prognostic Impact of Weight Change During Adjuvant Chemotherapy in Patients With High-Risk Early Breast Cancer: Results From the ADEBAR Study.
    Clin Breast Cancer. 2018;18:175-183.
    PubMed     Text format     Abstract available


    March 2018
  201. CORTES J, Perez-Garcia J, Whiting S, Wan Y, et al
    Quality-Adjusted Survival With nab-Paclitaxel Versus Standard Paclitaxel in Metastatic Breast Cancer: A Q-TWiST Analysis.
    Clin Breast Cancer. 2018 Mar 30. pii: S1526-8209(17)30778.
    PubMed     Text format     Abstract available


  202. KIM S, Moon BI, Lim W, Park S, et al
    Feasibility of Classification of Triple Negative Breast Cancer by Immunohistochemical Surrogate Markers.
    Clin Breast Cancer. 2018 Mar 23. pii: S1526-8209(17)30736.
    PubMed     Text format     Abstract available


  203. TAHERIPANAH R, Balash F, Anbiaee R, Mahmoodi M, et al
    Breast Cancer and Ovulation Induction Treatments.
    Clin Breast Cancer. 2018 Mar 15. pii: S1526-8209(17)30455.
    PubMed     Text format     Abstract available


  204. MORRIS PG, Rota S, Cadoo K, Zamora S, et al
    Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer.
    Clin Breast Cancer. 2018 Mar 15. pii: S1526-8209(17)30810.
    PubMed     Text format     Abstract available


  205. UM E, Kang JW, Lee S, Kim HJ, et al
    Comparing Accuracy of Mammography and Magnetic Resonance Imaging for Residual Calcified Lesions in Breast Cancer Patients Undergoing Neoadjuvant Systemic Therapy.
    Clin Breast Cancer. 2018 Mar 15. pii: S1526-8209(17)30614.
    PubMed     Text format     Abstract available


  206. MATTHIESSEN LW, Keshtgar M, Curatolo P, Kunte C, et al
    Electrochemotherapy for Breast Cancer-Results From the INSPECT Database.
    Clin Breast Cancer. 2018 Mar 14. pii: S1526-8209(17)30397.
    PubMed     Text format     Abstract available


  207. REINERT T, Nogueira-Rodrigues A, Kestelman FP, Ashton-Prolla P, et al
    The Challenge of Evaluating Adnexal Masses in Patients With Breast Cancer.
    Clin Breast Cancer. 2018 Mar 12. pii: S1526-8209(18)30026.
    PubMed     Text format     Abstract available


  208. MIYAGAWA Y, Araki K, Bun A, Ozawa H, et al
    Significant Association Between Low Baseline Neutrophil-to-Lymphocyte Ratio and Improved Progression-free Survival of Patients With Locally Advanced or Metastatic Breast Cancer Treated With Eribulin But Not With Nab-Paclitaxel.
    Clin Breast Cancer. 2018 Mar 8. pii: S1526-8209(17)30724.
    PubMed     Text format     Abstract available


  209. COSPHIADI I, Atmakusumah TD, Siregar NC, Muthalib A, et al
    Bone Metastasis in Advanced Breast Cancer: Analysis of Gene Expression Microarray.
    Clin Breast Cancer. 2018 Mar 8. pii: S1526-8209(17)30777.
    PubMed     Text format     Abstract available


  210. YARDLEY DA, Hart LL, Ward PJ, Wright GL, et al
    Cabazitaxel Plus Lapatinib as Therapy for HER2(+) Metastatic Breast Cancer With Intracranial Metastases: Results of a Dose-finding Study.
    Clin Breast Cancer. 2018 Mar 8. pii: S1526-8209(17)30668.
    PubMed     Text format     Abstract available


  211. MEATTINI I, Pezzulla D, Saieva C, Bernini M, et al
    Triple Negative Apocrine Carcinomas as a Distinct Subtype of Triple Negative Breast Cancer: A Case-control Study.
    Clin Breast Cancer. 2018 Mar 2. pii: S1526-8209(18)30015.
    PubMed     Text format     Abstract available


    February 2018
  212. BINKLEY JM, Stratford P, Kirkpatrick S, Farley CR, et al
    Estimating the Reliability and Validity of the Upper Extremity Functional Index in Women After Breast Cancer Surgery.
    Clin Breast Cancer. 2018 Feb 21. pii: S1526-8209(18)30054.
    PubMed     Text format     Abstract available


  213. DEFAZIO MV, Dervishaj OA, Bozzuto LM, Pittman TA, et al
    Delayed Recurrent and Bilateral Breast Cancer in Patients With Partial Poland's Anomaly: Report of 2 Rare Cases and Review of the Literature.
    Clin Breast Cancer. 2018 Feb 20. pii: S1526-8209(17)30842.
    PubMed     Text format    


  214. HERSKOVIC AC, Wu X, Christos PJ, Nagar H, et al
    Omission of Adjuvant Radiotherapy in the Elderly Breast Cancer Patient: Missed Opportunity?
    Clin Breast Cancer. 2018 Feb 20. pii: S1526-8209(17)30782.
    PubMed     Text format     Abstract available


  215. RAO N, Chen K, Yang Q, Niu J, et al
    Proof-of-Concept Study of 3-D-Printed Mold-Guided Breast-Conserving Surgery in Breast Cancer Patients.
    Clin Breast Cancer. 2018 Feb 20. pii: S1526-8209(18)30039.
    PubMed     Text format     Abstract available


  216. YAMASHITA N, Tokunaga E, Iimori M, Inoue Y, et al
    Epithelial Paradox: Clinical Significance of Coexpression of E-cadherin and Vimentin With Regard to Invasion and Metastasis of Breast Cancer.
    Clin Breast Cancer. 2018 Feb 16. pii: S1526-8209(17)30629.
    PubMed     Text format     Abstract available


  217. ZAHEDI H, Djalalinia S, Sadeghi O, Asayesh H, et al
    Dietary Inflammatory Potential Score and Risk of Breast Cancer: Systematic Review and Meta-analysis.
    Clin Breast Cancer. 2018 Feb 7. pii: S1526-8209(17)30725.
    PubMed     Text format     Abstract available


  218. PALAZZO A, Dellapasqua S, Munzone E, Bagnardi V, et al
    Phase II Trial of Bevacizumab Plus Weekly Paclitaxel, Carboplatin, and Metronomic Cyclophosphamide With or Without Trastuzumab and Endocrine Therapy as Preoperative Treatment of Inflammatory Breast Cancer.
    Clin Breast Cancer. 2018 Feb 2. pii: S1526-8209(17)30737.
    PubMed     Text format     Abstract available


  219. CUI Q, Kong D, Li Z, Ahiable P, et al
    Dachshund 1 is Differentially Expressed Between Male and Female Breast Cancer: A Matched Case-Control Study of Clinical Characteristics and Prognosis.
    Clin Breast Cancer. 2018 Feb 2. pii: S1526-8209(17)30662.
    PubMed     Text format     Abstract available


  220. BLACKWELL K, Gligorov J, Jacobs I, Twelves C, et al
    The Global Need for a Trastuzumab Biosimilar for Patients With HER2-Positive Breast Cancer.
    Clin Breast Cancer. 2018 Feb 2. pii: S1526-8209(17)30406.
    PubMed     Text format     Abstract available


    January 2018
  221. HASHEMI M, Sanaei S, Hashemi SM, Eskandari E, et al
    Association of Single Nucleotide Polymorphisms of the MDM4 Gene With the Susceptibility to Breast Cancer in a Southeast Iranian Population Sample.
    Clin Breast Cancer. 2018 Jan 31. pii: S1526-8209(17)30804.
    PubMed     Text format     Abstract available


  222. ERSOY YE, Kadioglu H
    Review of Novel Sentinel Lymph Node Biopsy Techniques in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2018 Jan 31. pii: S1526-8209(17)30830.
    PubMed     Text format     Abstract available


  223. JABIR FA, Hoidy WH
    Pharmacogenetics as Personalized Medicine: Association Investigation of SOD2 rs4880, CYP2C19 rs4244285, and FCGR2A rs1801274 Polymorphisms in a Breast Cancer Population in Iraqi Women.
    Clin Breast Cancer. 2018 Jan 31. pii: S1526-8209(17)30534.
    PubMed     Text format     Abstract available


  224. FARD ZT, Nafisi N
    The Relationship Between 6 Polymorphisms of Caveolin-1 Gene and the Risk of Breast Cancer.
    Clin Breast Cancer. 2018 Jan 31. pii: S1526-8209(16)30439.
    PubMed     Text format     Abstract available


  225. KOJIMA Y, Kawamoto H, Nishikawa T, Hayami R, et al
    Feasibility Study of Weekly Nanoparticle Albumin-Bound Paclitaxel (150 mg/m(2)) Followed by Fluorouracil, Epirubicin, and Cyclophosphamide Therapy as Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer.
    Clin Breast Cancer. 2018 Jan 11. pii: S1526-8209(17)30615.
    PubMed     Text format     Abstract available


  226. GU J, Groot G, Boden C, Busch A, et al
    Review of Factors Influencing Women's Choice of Mastectomy Versus Breast Conserving Therapy in Early Stage Breast Cancer: A Systematic Review.
    Clin Breast Cancer. 2018 Jan 3. pii: S1526-8209(17)30691.
    PubMed     Text format     Abstract available


    December 2017
  227. YADAV S, Ladkany R, Yadav D, Alhalabi O, et al
    Impact of BRCA Mutation Status on Survival of Women With Triple-negative Breast Cancer.
    Clin Breast Cancer. 2017 Dec 30. pii: S1526-8209(17)30334.
    PubMed     Text format     Abstract available


  228. WU JD, Hong CQ, Huang WH, Wei XL, et al
    L1 Cell Adhesion Molecule and Its Soluble Form sL1 Exhibit Poor Prognosis in Primary Breast Cancer Patients.
    Clin Breast Cancer. 2017 Dec 28. pii: S1526-8209(17)30523.
    PubMed     Text format     Abstract available


  229. BHAVE MA, Speth KA, Kidwell KM, Lyden A, et al
    Effect of Aromatase Inhibitor Therapy on Sleep and Activity Patterns in Early-stage Breast Cancer.
    Clin Breast Cancer. 2017 Dec 27. pii: S1526-8209(17)30624.
    PubMed     Text format     Abstract available


  230. MORIKAWA A, Wang R, Patil S, Diab A, et al
    Characteristics and Prognostic Factors for Patients With HER2-overexpressing Breast Cancer and Brain Metastases in the Era of HER2-targeted Therapy: An Argument for Earlier Detection.
    Clin Breast Cancer. 2017 Dec 21. pii: S1526-8209(17)30394.
    PubMed     Text format     Abstract available


  231. GORNSTEIN EL, Sandefur S, Chung JH, Gay LM, et al
    BRCA2 Reversion Mutation Associated With Acquired Resistance to Olaparib in Estrogen Receptor-positive Breast Cancer Detected by Genomic Profiling of Tissue and Liquid Biopsy.
    Clin Breast Cancer. 2017 Dec 21. pii: S1526-8209(17)30680.
    PubMed     Text format    


  232. YERUVA SLH, Javadi MS, Stearns V
    Complete Response to Single-agent Palbociclib in Metastatic Breast Cancer: A Case Report.
    Clin Breast Cancer. 2017 Dec 21. pii: S1526-8209(17)30533.
    PubMed     Text format    


  233. MEISEL J, Zhang C, Neely C, Mendoza P, et al
    Evaluation of Prognosis in Hormone Receptor-Positive/HER2-Negative and Lymph Node-Negative Breast Cancer With Low Oncotype DX Recurrence Score.
    Clin Breast Cancer. 2017 Dec 14. pii: S1526-8209(17)30562.
    PubMed     Text format     Abstract available


  234. MOLDERINGS GJ, Knuchel-Clarke R, Hertfelder HJ, Kuhl C, et al
    Mast Cell Activation Syndrome Mimicking Breast Cancer: Case Report With Pathophysiologic Considerations.
    Clin Breast Cancer. 2017 Dec 12. pii: S1526-8209(17)30532.
    PubMed     Text format    


  235. KUBA S, Maeda S, Matsumoto M, Yamanouchi K, et al
    Adherence to Adjuvant Endocrine Therapy in Women With Breast Cancer: A Prospective Observational Study in Japanese Women.
    Clin Breast Cancer. 2017 Dec 12. pii: S1526-8209(17)30626.
    PubMed     Text format     Abstract available


  236. SHEPPARD VB, de Mendoza AH, He J, Jennings Y, et al
    Initiation of Adjuvant Endocrine Therapy in Black and White Women With Breast Cancer.
    Clin Breast Cancer. 2017 Dec 12. pii: S1526-8209(17)30356.
    PubMed     Text format     Abstract available


  237. CHIBA A, Raman R, Thomas A, Lamy PJ, et al
    Serum Vitamin D Levels Affect Pathologic Complete Response in Patients Undergoing Neoadjuvant Systemic Therapy for Operable Breast Cancer.
    Clin Breast Cancer. 2017 Dec 11. pii: S1526-8209(17)30324.
    PubMed     Text format     Abstract available


  238. ELGHOROURY EA, ElDine HG, Kamel SA, Abdelrahman AH, et al
    Evaluation of miRNA-21 and miRNA Let-7 as Prognostic Markers in Patients With Breast Cancer.
    Clin Breast Cancer. 2017 Dec 7. pii: S1526-8209(17)30458.
    PubMed     Text format     Abstract available


  239. SCIMECA M, Antonacci C, Toschi N, Giannini E, et al
    Breast Osteoblast-like Cells: A Reliable Early Marker for Bone Metastases From Breast Cancer.
    Clin Breast Cancer. 2017 Dec 5. pii: S1526-8209(17)30209.
    PubMed     Text format     Abstract available


    November 2017
  240. BASTIAANNET E, Charman J, Johannesen TB, Schrodi S, et al
    A European, Observational Study of Endocrine Therapy Administration in Patients With an Initial Diagnosis of Hormone Receptor-Positive Advanced Breast Cancer.
    Clin Breast Cancer. 2017 Nov 29. pii: S1526-8209(17)30728.
    PubMed     Text format     Abstract available


  241. LANDMAN Y, Ilouze M, Wein S, Neiman V, et al
    Rapid Response to Larotrectinib (LOXO-101) in an Adult Chemotherapy-Naive Patients With Advanced Triple-Negative Secretory Breast Cancer Expressing ETV6-NTRK3 Fusion.
    Clin Breast Cancer. 2017 Nov 28. pii: S1526-8209(17)30561.
    PubMed     Text format    


  242. HAMELINCK VC, Bastiaannet E, Pieterse AH, van de Velde CJH, et al
    Preferred and Perceived Participation of Younger and Older Patients in Decision Making About Treatment for Early Breast Cancer: A Prospective Study.
    Clin Breast Cancer. 2017 Nov 28. pii: S1526-8209(17)30409.
    PubMed     Text format     Abstract available


  243. RASOOL I, Afroze D, Wani KA, Yousuf A, et al
    Role of the Functional Polymorphism of Survivin Gene (-31G/C) and Risk of Breast Cancer in a North Indian Population.
    Clin Breast Cancer. 2017 Nov 23. pii: S1526-8209(17)30631.
    PubMed     Text format     Abstract available


  244. FURRER D, Jacob S, Michaud A, Provencher L, et al
    Association of Tobacco Use, Alcohol Consumption and HER2 Polymorphisms With Response to Trastuzumab in HER2-Positive Breast Cancer Patients.
    Clin Breast Cancer. 2017 Nov 23. pii: S1526-8209(17)30318.
    PubMed     Text format     Abstract available


  245. FLEMING CA, McCarthy K, Ryan C, McCarthy A, et al
    Evaluation of Discordance in Primary Tumor and Lymph Node Response After Neoadjuvant Therapy in Breast Cancer.
    Clin Breast Cancer. 2017 Nov 23. pii: S1526-8209(17)30679.
    PubMed     Text format     Abstract available


  246. CHANG HT, Pan HJ, Lee CH
    Prevention of Tamoxifen-related Nonalcoholic Fatty Liver Disease in Breast Cancer Patients.
    Clin Breast Cancer. 2017 Nov 23. pii: S1526-8209(17)30357.
    PubMed     Text format     Abstract available


  247. KIM JY, Jung EJ, Park HJ, Lee JH, et al
    Tumor-Suppressing Effect of Silencing of Annexin A3 Expression in Breast Cancer.
    Clin Breast Cancer. 2017 Nov 21. pii: S1526-8209(17)30504.
    PubMed     Text format     Abstract available


  248. INOUE Y, Yamashita N, Kitao H, Tanaka K, et al
    Clinical Significance of the Wild Type p53-Induced Phosphatase 1 Expression in Invasive Breast Cancer.
    Clin Breast Cancer. 2017 Nov 21. pii: S1526-8209(17)30385.
    PubMed     Text format     Abstract available


  249. GRANDI G, Toss A, Cagnacci A, Marcheselli L, et al
    Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History.
    Clin Breast Cancer. 2017 Nov 14. pii: S1526-8209(17)30488.
    PubMed     Text format     Abstract available


  250. CHKHEIDZE R, Sanders MAG, Haley B, Leitch AM, et al
    Isolated Contralateral Axillary Lymph Node Involvement in Breast Cancer Represents a Locally Advanced Disease Not Distant Metastases.
    Clin Breast Cancer. 2017 Nov 10. pii: S1526-8209(17)30456.
    PubMed     Text format     Abstract available


  251. KARAKAS Y, Dizdar O, Aksoy S, Hayran M, et al
    The Effect of Total Size of Lesions in Multifocal/Multicentric Breast Cancer on Survival.
    Clin Breast Cancer. 2017 Nov 9. pii: S1526-8209(17)30449.
    PubMed     Text format     Abstract available


  252. HOU Y, Nitta H, Wei L, Banks PM, et al
    Evaluation of Immune Reaction and PD-L1 Expression Using Multiplex Immunohistochemistry in HER2-Positive Breast Cancer: The Association With Response to Anti-HER2 Neoadjuvant Therapy.
    Clin Breast Cancer. 2017 Nov 9. pii: S1526-8209(17)30604.
    PubMed     Text format     Abstract available


  253. RAGHAVENDRA A, Sinha AK, Valle J, Shen Y, et al
    Determinants of Weight Gain During Adjuvant Endocrine Therapy and Association of Such Weight Gain With Recurrence in Long-term Breast Cancer Survivors.
    Clin Breast Cancer. 2017 Nov 9. pii: S1526-8209(17)30621.
    PubMed     Text format     Abstract available


  254. FIGUEIREDO FWDS, Adami F
    Income Inequality and Mortality Owing to Breast Cancer: Evidence From Brazil.
    Clin Breast Cancer. 2017 Nov 9. pii: S1526-8209(17)30526.
    PubMed     Text format     Abstract available


  255. WADASADAWALA T, Lewis S, Parmar V, Budrukkar A, et al
    Bilateral Breast Cancer After Multimodality Treatment: A Report of Clinical Outcomes in an Asian Population.
    Clin Breast Cancer. 2017 Nov 9. pii: S1526-8209(17)30383.
    PubMed     Text format     Abstract available


  256. FISCHER A, Ziogas A, Anton-Culver H
    Negative Valence Life Events Promote Breast Cancer Development.
    Clin Breast Cancer. 2017 Nov 1. pii: S1526-8209(16)30501.
    PubMed     Text format     Abstract available


    October 2017
  257. MCREE AJ, Marcom PK, Moore DT, Zamboni WC, et al
    A Phase I Trial of the PI3K Inhibitor Buparlisib Combined With Capecitabine in Patients With Metastatic Breast Cancer.
    Clin Breast Cancer. 2017 Oct 28. pii: S1526-8209(17)30313.
    PubMed     Text format     Abstract available


  258. MCVEIGH TP, Wiggins J, Ward S, Kemp Z, et al
    Successful Repatriation of Breast Cancer Surveillance for High-Risk Women to the UK National Health Service Breast Screening Programme.
    Clin Breast Cancer. 2017 Oct 28. pii: S1526-8209(17)30489.
    PubMed     Text format     Abstract available


  259. PROCHOWSKI IAMURRI A, Ponziani M, Macchini M, Fogante M, et al
    Evaluation of Multifocality and Multicentricity With Breast Magnetic Resonance Imaging in Each Breast Cancer Subtype.
    Clin Breast Cancer. 2017 Oct 28. pii: S1526-8209(17)30164.
    PubMed     Text format     Abstract available


  260. SALOUSTROS E, Nikolaou M, Kalbakis K, Polyzos A, et al
    Weekly Paclitaxel and Carboplatin Plus Bevacizumab as First-Line Treatment of Metastatic Triple-Negative Breast Cancer. A Multicenter Phase II Trial by the Hellenic Oncology Research Group.
    Clin Breast Cancer. 2017 Oct 24. pii: S1526-8209(17)30153.
    PubMed     Text format     Abstract available


  261. HARDEFELDT PJ, Penninkilampi R, Edirimanne S, Eslick GD, et al
    Physical Activity and Weight Loss Reduce the Risk of Breast Cancer: A Meta-analysis of 139 Prospective and Retrospective Studies.
    Clin Breast Cancer. 2017 Oct 17. pii: S1526-8209(16)30429.
    PubMed     Text format     Abstract available


  262. KUROSKY SK, Mitra D, Zanotti G, Kaye JA, et al
    Treatment Patterns and Outcomes of Patients With Metastatic ER(+)/HER-2(-) Breast Cancer: A Multicountry Retrospective Medical Record Review.
    Clin Breast Cancer. 2017 Oct 14. pii: S1526-8209(17)30060.
    PubMed     Text format     Abstract available


  263. CHANG AE, Wu QV, Jenkins IC, Specht JM, et al
    Phase I/II Trial of Combined Pegylated Liposomal Doxorubicin and Cyclophosphamide in Metastatic Breast Cancer.
    Clin Breast Cancer. 2017 Oct 9. pii: S1526-8209(17)30280.
    PubMed     Text format     Abstract available


  264. JANDIAL R, Hoshide R, Waters JD, Somlo G, et al
    Operative and Therapeutic Advancements in Breast Cancer Metastases to the Brain.
    Clin Breast Cancer. 2017 Oct 7. pii: S1526-8209(17)30417.
    PubMed     Text format     Abstract available


  265. HIEKEN TJ, Murphy BL, Boughey JC, Degnim AC, et al
    Influence of Biologic Subtype of Inflammatory Breast Cancer on Response to Neoadjuvant Therapy and Cancer Outcomes.
    Clin Breast Cancer. 2017 Oct 7. pii: S1526-8209(17)30370.
    PubMed     Text format     Abstract available


  266. RAISS H, Peron J, Tartas S, Trillet-Lenoir V, et al
    Palbociclib-Induced Thrombotic Microangiopathy in Metastatic Breast Cancer Patient Surviving for 18 Years: Case Report and Review of the Literature.
    Clin Breast Cancer. 2017 Oct 7. pii: S1526-8209(17)30072.
    PubMed     Text format    


  267. HAYASHI N, Takahashi Y, Matsuda N, Tsunoda H, et al
    The Prognostic Effect of Changes in Tumor Stage and Nodal Status After Neoadjuvant Chemotherapy in Each Primary Breast Cancer Subtype.
    Clin Breast Cancer. 2017 Oct 3. pii: S1526-8209(17)30319.
    PubMed     Text format     Abstract available


    September 2017
  268. HOUSSAMI N
    Evidence on Synthesized Two-dimensional Mammography Versus Digital Mammography When Using Tomosynthesis (Three-dimensional Mammography) for Population Breast Cancer Screening.
    Clin Breast Cancer. 2017 Sep 28. pii: S1526-8209(17)30558.
    PubMed     Text format     Abstract available


  269. HEGDE JV, Wang X, Attai DJ, DiNome ML, et al
    Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
    Clin Breast Cancer. 2017 Sep 27. pii: S1526-8209(17)30512.
    PubMed     Text format     Abstract available


  270. ITO T, Oura S, Nagamine S, Takahashi M, et al
    Radiofrequency Ablation of Breast Cancer: A Retrospective Study.
    Clin Breast Cancer. 2017 Sep 25. pii: S1526-8209(17)30241.
    PubMed     Text format     Abstract available


  271. LEAL AD, Van Houten H, Sangaralingham L, Freedman RA, et al
    Breast Cancer Survivorship Care Variations Between Adjuvant Chemotherapy Regimens.
    Clin Breast Cancer. 2017 Sep 22. pii: S1526-8209(17)30422.
    PubMed     Text format     Abstract available


  272. AKIMOTO E, Kadoya T, Kajitani K, Emi A, et al
    Role of 18F-PET/CT in Predicting Prognosis of Patients With Breast Cancer After Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30037.
    PubMed     Text format     Abstract available


  273. WU J, Wang S, Liu F, Li S, et al
    Single Nucleotide Polymorphisms in the Acylphosphatase 2 Gene and The SNP-SNP Interactions on the Risk of Breast Cancer in Chinese Han Women.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30157.
    PubMed     Text format     Abstract available


  274. DIANATINASAB M, Mohammadianpanah M, Daneshi N, Zare-Bandamiri M, et al
    Socioeconomic Factors, Health Behavior, and Late-Stage Diagnosis of Breast Cancer: Considering the Impact of Delay in Diagnosis.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30358.
    PubMed     Text format     Abstract available


  275. MANN JM, Wu X, Christos P, Nagar H, et al
    The State of Surgical Axillary Management and Adjuvant Radiotherapy for Early-stage Invasive Breast Cancer in the Modern Era.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30461.
    PubMed     Text format     Abstract available


  276. SAFRA T, Kaufman B, Kadouri L, Efrat Ben-Baruch N, et al
    Everolimus Plus Letrozole for Treatment of Patients With HR+, HER2- Advanced Breast Cancer Progressing on Endocrine Therapy: An Open-label, Phase II Trial.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30180.
    PubMed     Text format     Abstract available


  277. SPINELLI VARELLA MA, Teixeira da Cruz J, Rauber A, Varella IS, et al
    Role of BI-RADS Ultrasound Subcategories 4A to 4C in Predicting Breast Cancer.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(16)30505.
    PubMed     Text format     Abstract available


  278. OBERGUGGENBERGER A, Meraner V, Sztankay M, Hilbert A, et al
    Health Behavior and Quality of Life Outcome in Breast Cancer Survivors: Prevalence Rates and Predictors.
    Clin Breast Cancer. 2017 Sep 18. pii: S1526-8209(17)30454.
    PubMed     Text format     Abstract available


  279. FERNANDEZ-GONZALEZ S, Falo C, Pla MJ, Pernas S, et al
    The Shift From Sentinel Lymph Node Biopsy Performed Either Before or After Neoadjuvant Systemic Therapy in the Clinical Negative Nodes of Breast Cancer Patients. Results, and the Advantages and Disadvantages of Both Procedures.
    Clin Breast Cancer. 2017 Sep 4. pii: S1526-8209(17)30565.
    PubMed     Text format     Abstract available


  280. ANAMPA J, Chen A, Wright J, Patel M, et al
    Phase I Trial of Veliparib, a Poly ADP Ribose Polymerase Inhibitor, Plus Metronomic Cyclophosphamide in Metastatic HER2-negative Breast Cancer.
    Clin Breast Cancer. 2017 Sep 1. pii: S1526-8209(17)30468.
    PubMed     Text format     Abstract available


  281. ROGOZ B, Houze de l'Aulnoit A, Duhamel A, Houze de l'Aulnoit D, et al
    Thirty-Year Trends of Survival and Time-Varying Effects of Prognostic Factors in Patients With Metastatic Breast Cancer-A Single Institution Experience.
    Clin Breast Cancer. 2017 Sep 1. pii: S1526-8209(16)30427.
    PubMed     Text format     Abstract available


    August 2017
  282. CHAMP CE, Ohri N, Klement RJ, Cantor M, et al
    Assessing Changes in the Activity Levels of Breast Cancer Patients During Radiation Therapy.
    Clin Breast Cancer. 2017 Aug 24. pii: S1526-8209(17)30285.
    PubMed     Text format     Abstract available


  283. CHAO YL, Anders CK
    TYMS Gene Polymorphisms in Breast Cancer Patients Receiving 5-Fluorouracil-Based Chemotherapy.
    Clin Breast Cancer. 2017 Aug 19. pii: S1526-8209(17)30369.
    PubMed     Text format    


  284. WANG Y, Brodsky AS, Xiong J, Lopresti ML, et al
    Stromal Clusterin Expression Predicts Therapeutic Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer.
    Clin Breast Cancer. 2017 Aug 19. pii: S1526-8209(17)30349.
    PubMed     Text format     Abstract available


  285. CID S, Eiro N, Fernandez B, Sanchez R, et al
    Prognostic Influence of Tumor Stroma on Breast Cancer Subtypes.
    Clin Breast Cancer. 2017 Aug 19. pii: S1526-8209(17)30189.
    PubMed     Text format     Abstract available


  286. CHOI WJ, Kim WK, Shin HJ, Cha JH, et al
    Evaluation of the Tumor Response After Neoadjuvant Chemotherapy in Breast Cancer Patients: Correlation Between Dynamic Contrast-enhanced Magnetic Resonance Imaging and Pathologic Tumor Cellularity.
    Clin Breast Cancer. 2017 Aug 18. pii: S1526-8209(17)30058.
    PubMed     Text format     Abstract available


  287. AZIM HA, Abdel-Malek R, Kassem L
    Predicting Brain Metastasis in Breast Cancer Patients: Stage Versus Biology.
    Clin Breast Cancer. 2017 Aug 18. pii: S1526-8209(17)30235.
    PubMed     Text format     Abstract available


  288. KOOL M, Bastiaannet E, Van de Velde CJH, Marang-van de Mheen PJ, et al
    Reliability of Self-reported Treatment Data by Patients With Breast Cancer Compared With Medical Record Data.
    Clin Breast Cancer. 2017 Aug 18. pii: S1526-8209(17)30212.
    PubMed     Text format     Abstract available


  289. DONG H, Huang Y, Song F, Dai H, et al
    Improved Performance of Adjunctive Ultrasonography After Mammography Screening for Breast Cancer Among Chinese Females.
    Clin Breast Cancer. 2017 Aug 15. pii: S1526-8209(17)30321.
    PubMed     Text format     Abstract available


  290. CHEN W, Huang Y, Lewis GD, Szeja SS, et al
    Treatment Outcomes and Prognostic Factors in Male Patients With Stage IV Breast Cancer: A Population-based Study.
    Clin Breast Cancer. 2017 Aug 10. pii: S1526-8209(17)30185.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: